RP72 Monotherapy and in Combination With Gemcitabine in Patients With Pancreatic Cancer
Clinical trial NCT04338763 · UNKNOWN
Trial details
- NCT number
- NCT04338763
- Sponsor
- Rise Biopharmaceuticals, Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-19
- Primary completion
- 2024-10-31
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.